Phillips Andrew John
Director at ELVN
- Sold, on record
- None
- Dollars the filings state
- Form 4 sales
- 0
- None on record
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ELVNEnliven Therapeutics, Inc.Director
Sales by reason
No Form 4 sale on record for Phillips Andrew John.
Timeline
- Mar 31, 2026Notice
Filed a notice to sell 26,035 shares
$1M26,035 shares
- Feb 2, 2026Notice
Filed a notice to sell 21,844 shares
$612k21,844 shares
2 of 2
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | Aug 11, 2026 | OKUR | Director | AwardedStock Option (right to buy) | 22,350 | 22,350 | SEC | ||
| Jun 17, 2026 | Jun 18, 2026 | MLTX | Director | AwardedOption to Buy | 22,195 | 22,195 | SEC | ||
| Jun 4, 2026 | Jun 8, 2026 | OKUR | Director | AwardedStock Option (right to buy) | 7,650 | 7,650 | SEC | ||
| Jun 5, 2025 | Jun 9, 2025 | MLTX | Director | AwardedOption to Buy | 6,682 | 6,682 | SEC | ||
| May 28, 2025 | May 30, 2025 | OKUR | Director | AwardedStock Option (right to buy) | 7,650 | 7,650 | SEC | ||
| Feb 6, 2025 | Feb 10, 2025 | ELVN | Director | AwardedStock Option (right to buy) | 20,491 | 20,491 | SEC | ||
| Oct 4, 2024 | Oct 8, 2024 | OKUR | Director | AwardedStock Option (right to buy) | 15,300 | 15,300 | SEC | ||
| Jun 6, 2024 | Jun 7, 2024 | MLTX | Director | AwardedOption to Buy | 7,688 | 7,688 | SEC | ||
| Feb 13, 2024 | Feb 15, 2024 | ELVN | Director | AwardedStock Option (right to buy) | 16,835 | 16,835 | SEC | ||
| Jun 8, 2023 | Jun 12, 2023 | MLTX | Director | AwardedOption to Buy | 11,297 | 11,297 | SEC | ||
| Feb 23, 2023 | Apr 6, 2023 | ELVN | Director | AwardedStock Option (right to buy) | 27,567 | 27,567 | SEC | ||
| Apr 6, 2022 | May 5, 2022 | MLTX | Director | AwardedOption to Buy | 45,000 | 45,000 | SEC |